セッション情報

FACO Plenary Session

第56回・2018年・横浜
FACO Plenary Session
FACO Plenary Session 1
FACO Plenary Session 1
開催回
第56回・2018年・横浜

Genetic landscape of prior and resistance to CDK4/6 inhibition in targeted NGS panel analysis of palbociclib or abemaciclib and endocrine versus placebo and endocrine

演題番号 : FPS1-1

Speaker）Junnan Xu:1、Tao Sun:1、Xiangyu Guo:1、Mingxi Jing:1

1:Department of Medical Oncology, Cancer Hospital of China Medical University, China
Genetic landscape of prior and resistance to CDK4/6 inhibition in targeted NGS panel analysis of palbociclib or abemaciclib and endocrine versus placebo and endocrine

The accuracy of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: a retrospective analysis and a prospective study of the Chinese population

演題番号 : FPS1-2

Speaker）Jiaqi Liu:1、Xin Wang:1、Wenyan Wang:2、Jie Wang:1、Zeyu Xing:1、Menglu Zhang:1、Xiangzhi Meng:1、Shudong Yan:1、Tianyi Qian:1、Xiang Wang:1

1:Department of Breast Surgical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China、2:Breast Department, Beijing Tiantan Hospital, China
The accuracy of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: a retrospective analysis and a prospective study of the Chinese population

演題取り下げ

演題番号 : FPS1-3
演題取り下げ

The TGFb-induced lncRNA TBILA promotes non-small cell lung cancer progression via cis-regulating HGAL and activating S100A7-JAB1 signaling

演題番号 : FPS1-4

Speaker）Zhiliang Lu:1、Yuan Li:1、Yun Che:1、Jianbing Huang:1、Shouguo Sun:1、Shuangshuang Mao:1、Yuanyuan Lei:1、Ning Li:1、Nan Sun:1、Jie He:1

1:Department of Thoracic Surgery, National Caner Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking union Medical College, China
The TGFb-induced lncRNA TBILA promotes non-small cell lung cancer progression via cis-regulating HGAL and activating S100A7-JAB1 signaling

演題取り下げ

演題番号 : FPS1-5
演題取り下げ

Toll-like receptor 9 agonists: a novel therapeutic agent for multiple anti-acute lymphocytic leukemia effects

演題番号 : FPS1-6

Speaker）Jiuwei Cui:1、Ling Bai:1、Wei Chen:2、Wei Li:1、Lei Zhou:1、Chao Niu:1、Wei Han:1、Xiaoying Zhang:1、Yongchong Chen:1

1:Cancer Center, Jilin University, China、2:ADC Biomedical Research Institute, University of Minnesota, USA
Toll-like receptor 9 agonists: a novel therapeutic agent for multiple anti-acute lymphocytic leukemia effects